Search All News
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
Barring ovarian cancer surgery at low-volume hospitals could limit access to care for many rural and underserved patients, a new study has found.
- May 12, 2014
Two genes together drive the most lethal forms of prostate cancer; could lead to diagnostic test and new treatments.
- April 18, 2014
New bone marrow transplant unit specializes in cutting-edge treatments for blood cancers and autoimmune diseases.
- April 9, 2014
Important tips on sunglasses and sun exposure from NewYork-Presbyterian Hospital experts.
- April 3, 2014
Alfred Neugut, MD, PhD, says it may be time to make aspirin a part of the conventional standard of care for colon cancer.
- March 26, 2014
Early detection of retinoblastoma in children does not improve outcomes, suggests a Mailman study.
- February 20, 2014
The American Medical Association has honored P&S student Gregory Joice for his research.
- January 23, 2014
Breast cancer study in mice suggests that radiation therapy to unaffected breast could reduce risk of second cancer.
- January 21, 2014
Common type of leukemia may start with a change in bone cells.
- January 6, 2014
NewYork-Presbyterian/Columbia University Medical Center has named leading physician-scientist Dr. Gary Schwartz chief of the Division of Hematology/Oncology in the Department of Medicine and associate director for research of its Herbert Irving Comprehensive Cancer Center.